Dyadic to Attend J.P. Morgan 41st Annual Healthcare Conference
04 janv. 2023 08h30 HE
|
Dyadic International, Inc.
JUPITER, Fla., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
Dyadic's DYAI-100 COVID-19 Vaccine Study Published in a Leading Peer-Reviewed Scientific Journal
14 déc. 2022 08h30 HE
|
Dyadic International, Inc.
“Thermophilic Filamentous Fungus C1-Cell-Cloned SARS-CoV-2-Spike-RBD-Subunit-Vaccine Adjuvanted with Aldydrogel®85 Protects K18-hACE2 Mice against Lethal Virus Challenge” Study supports: Dyadic’s...
Dyadic to Present Disruptive C1 Technology at World Vaccine Congress Europe Announcing Expansion of Influenza Pipeline with Enhanced Efficacy Potential
04 oct. 2022 08h45 HE
|
Dyadic International, Inc.
JUPITER, Fla., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
Dyadic Reports Second Quarter 2022 Financial Results and Highlights Recent Company Developments
10 août 2022 16h00 HE
|
Dyadic International, Inc.
Submission of a Clinical Trial Application (CTA) with South African Health Products Regulatory Authority (SAHPRA) to initiate a Phase 1 study to support clinical safety of proteins produced from...
DEADLINE ALERT for SNAP, and NVAX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
10 janv. 2022 11h18 HE
|
The Law Offices of Frank R. Cruz
LOS ANGELES, Jan. 10, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Novavax, Inc. (NVAX)
05 janv. 2022 11h00 HE
|
Glancy Prongay & Murray LLP
LOS ANGELES, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming January 11, 2022 deadline to file a lead plaintiff motion in the class action...
DEADLINE ALERT for ONTF, SNAP, and NVAX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
03 janv. 2022 11h27 HE
|
The Law Offices of Frank R. Cruz
LOS ANGELES, Jan. 03, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
DEADLINE ALERT for ONTF, SNAP, NVAX, Z/ZG: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
03 janv. 2022 11h00 HE
|
Law Offices of Howard G. Smith
BENSALEM, Pa., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
SHAREHOLDER ALERT: ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages Novavax, Inc. Investors with Losses to Secure Counsel Before Important January 11 Deadline in Securities Class Action – NVAX
28 déc. 2021 14h57 HE
|
The Rosen Law Firm PA
NEW YORK, Dec. 28, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Novavax, Inc. (NASDAQ: NVAX) between March 2, 2021 and...
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Novavax, Inc. (NVAX)
27 déc. 2021 12h00 HE
|
Glancy Prongay & Murray LLP
LOS ANGELES, Dec. 27, 2021 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming January 11, 2022 deadline to file a lead plaintiff motion in the class action...